The Food and Drug Administration (FDA) is taking the first steps toward potentially easing access to certain peptide ...

Eli Lilly (LLY 1.85%) has accomplished something big over the past year. It's become the leading weight loss drug company in ...

Eli Lilly and Company India President and General Manager Winselow Tucker on Mounjaro’s rapid rise and the country’s unmet ...

Move over, “Ozempic itch.” A new side effect is raising alarm among experts, and it goes well beyond the physical effects ...

A study analysing over 400,000 social media posts identified the most common side effects of GLP-1 weight loss injections ...

Week Study Evaluates One-Step Dose Titration to 48 mg and Two-Step Dose Titration to 64 mg in Obese Otherwise Healthy Adults CAMBRIDGE, Mass., April 10, 2026 /PRNewswire/ ...

He suggested that she ask her doctor about trying a GLP-1 drug off-label, a common practice in which a medication is ...

Contracts signed for Animal Study GLP-1-A26-1 KELOWNA, BC / ACCESS Newswire / April 15, 2026 / Lexaria Bioscience Corp. (NASDAQ:LEXX), (the "Company" or "Lexaria"), a global innovator in drug delivery ...

Novo Nordisk (NYSE:NVO) reports first-quarter 2026 results on 6 May, with UBS flagging that the results will provide the ...

JOHNSON SPACE CENTER — Even though the IM-1 mission’s lunar lander Odysseus tipped over after landing on the moon last week, the company’s CEO called it a “successful mission” during a press ...

If you are overhearing people talking about injectable peptides and are wondering what on earth they are, here's an explainer ...

Tim Church, MD, PhD, MPH, explains that access to care—not willpower—is the central barrier to GLP-1 use, and says employer ...